drugset / Trial / NCT01133405
A Safety Study of LY2886721 Single Doses in Healthy Subjects
RandomizedCrossoverDouble-blindBasic science
Summary
This is a Phase 1 study in healthy subjects to evaluate the safety and tolerability of LY2886721 single doses, how the body handles the drug, and the drug's effect on the body.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-10
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2886721 | Small molecule | 7 mg | Oral |
| Subject | LY2886721 | Small molecule | 10 mg | Oral |
| Subject | LY2886721 | Small molecule | 15 mg | Oral |
| Subject | LY2886721 | Small molecule | 25 mg | Oral |
| Subject | LY2886721 | Small molecule | 35 mg | Oral |